Decision Guide
EUDAMED device registration

Service

Since May 28, 2026, the use of the first four EUDAMED modules has been mandatory: Actor Registration, UDI/Devices, Notified Bodies & Certificates, and Market Surveillance. This marked the beginning of a new phase in European medical device regulation for manufacturers, EU authorized representatives, Notified Bodies, and competent authorities. Further information and access to EUDAMED can be found here: EUDAMED

The following decision-making tool helps assess whether and by when a medical device or in vitro diagnostic medical device (IVD) must be registered in the EUDAMED UDI/DEV module. It takes into account the varying requirements for OLD DEVICES, LEGACY DEVICES, as well as MDR/IVDR products.

Mehrfachauswahl 01

Version dated 2026-06-18

Disclaimer:

Manufacturers of contact lenses should also take into account the specific provisions of MDCG
2024-14 Rev. 1 and MDCG Position Paper 2025-7 Rev. 1 concerning the implementation of the
Master UDI-DI and the associated registration timelines.
The conclusions presented are based on the legislation available at the time of preparation,
in particular the consolidated versions of Regulation (EU) 2017/745 (MDR) and Regulation
(EU) 2017/746 (IVDR), as well as the relevant publications of the European Commission
and the Medical Device Coordination Group (MDCG). The regulatory framework is subject
to continuous development. In addition to the legally binding legislation, numerous
guidance documents, position papers, question-and-answer documents and other
publications issued by European institutions and expert bodies exist, some of which address
or interpret specific issues differently. Furthermore, future legislative changes, new guidance
documents or further clarifications issued by the competent authorities may lead to different
conclusions on individual matters. Accordingly, this decision tree does not claim to provide
an exhaustive or generally binding legal interpretation. Rather, it is intended as a practical
guide based on the information currently available. We recommend that you continuously
monitor developments in the relevant legislation, MDCG documents, Commission
publications and EUDAMED-related guidelines, and regularly assess the implications
for your products, registrations and processes. Where necessary, this may require you to
take additional measures or adapt existing registration strategies.

Our LinkedIn profile

NEWS

Open vacancies

CAREER AT MDC

Subscribe our newsletter

DON’T MISS ANY MORE NEWS